Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone ResistancePatrick N. A. Harris, David L. Paterson, Paul Anantharajah Tambyah et al.|JAMA|2018Cited by 761
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, Juan Gálvez-Acebal et al.|The Lancet Infectious Diseases|2017Cited by 521
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter StudyMario Tumbarello, Pierluigi Viale, Francesca Raffaelli et al.|Clinical Infectious Diseases|2021Cited by 264
Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter studyGiovanni Volpicelli, Giulia Vezzoni, Luna Gargani et al.|Intensive Care Medicine|2021Cited by 183
Platelet Activation Is Associated With Myocardial Infarction in Patients With PneumoniaRoberto Cangemi, Ines Ullo, Marco Casciaro et al.|Journal of the American College of Cardiology|2014Cited by 159